Noise
Trump Administration Announces Medicare Drug Price Negotiation Program
2026-01-27 · 1 sources · 90% confidence
IF YOU ONLY DO ONE THING
Verify whether this represents actual policy change or continuation of existing Medicare negotiation authority established under the 2022 Inflation Reduction Act.
Why This Score
This is a continuation of the Biden-era Inflation Reduction Act's Medicare drug negotiation program, not a new Trump policy initiative. The announcement adds drugs to an existing framework with no constitutional implications (A=0). The modest B score (23) reflects credit-claiming for a predecessor's policy during a week crowded with higher-stakes events, fitting the 'credit-grab' noise pattern.
Damage Score Drivers
Election Integrity & Transfer of Power×0.22
0.0/5
Rule of Law / Due Process×0.18
0.0/5
Separation of Powers×0.16
0.0/5
Civil Rights / Equal Protection×0.14
0.0/5
Institutional Capture×0.14
0.0/5
Corruption / Self-Dealing×0.1
0.0/5
Violence / Intimidation Enabling×0.06
0.0/5
Sev: durability=1 · reversibility=1 · precedent=0.8 · mech=1.05× scope=1.1×
Hype Score: Layer 1 — Hype (55%)
Outrage-bait
0.0/5
Meme-ability
0.0/5
Novelty Spike
1.0/5
Media Friendliness
2.0/5
Layer 2 — Strategic (45%)
Media-Volume Mismatch
1.0/5
Timing Overlap
0.0/5
Narrative Pivot
1.0/5
Repeat Pattern Match
2.0/5
Intentionality: 5/15 → Reduced (0.25)